Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| BridgeBio Oncology Therapeutics, Inc. | 45,623 | reported | 01 Apr 2026 | tx 4+613,847−1,047 |
| Corbus Pharmaceuticals Holdings, Inc. | 11,383 | reported | 19 May 2026 | tx 8+53,073 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 19 May 2026 | GRANT_AWARD | Corbus Pharmaceuticals Holdings, Inc. | 3,800 | 0.00 USD | |
| 19 May 2026 | GRANT_AWARD | Corbus Pharmaceuticals Holdings, Inc. | 12,300 | 0.00 USD | deriv |
| 01 Apr 2026 | TAX_WITHHOLDING | BridgeBio Oncology Therapeutics, Inc. | 1,047 | 9.03 USD | |
| 10 Mar 2026 | GRANT_AWARD | BridgeBio Oncology Therapeutics, Inc. | 46,670 | 0.00 USD | |
| 10 Mar 2026 | GRANT_AWARD | BridgeBio Oncology Therapeutics, Inc. | 210,000 | 0.00 USD | deriv |
| 26 Aug 2025 | GRANT_AWARD | BridgeBio Oncology Therapeutics, Inc. | 357,177 | 0.00 USD | deriv |
| 30 May 2025 | GRANT_AWARD | Corbus Pharmaceuticals Holdings, Inc. | 4,800 | 0.00 USD | |
| 30 May 2025 | GRANT_AWARD | Corbus Pharmaceuticals Holdings, Inc. | 16,000 | 0.00 USD | deriv |
| 30 May 2024 | GRANT_AWARD | Corbus Pharmaceuticals Holdings, Inc. | 2,783 | 0.00 USD | |
| 16 May 2024 | GRANT_AWARD | Corbus Pharmaceuticals Holdings, Inc. | 2,783 | 0.00 USD | deriv |
| 18 May 2023 | GRANT_AWARD | Corbus Pharmaceuticals Holdings, Inc. | 5,300 | 0.00 USD | deriv |
| 06 Mar 2023 | GRANT_AWARD | Corbus Pharmaceuticals Holdings, Inc. | 5,307 | 0.00 USD | deriv |